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Abstract 
Objective: Oral Lichen Planus (OLP) is a chronic inflammatory disease with an autoimmune inflammatory patho-
genesis. The aim of the research is to compare the vascular endothelial growth factor (VEGF) and adhesion of 
molecules in the biopsy samples of patients affected by OLP, in order to research the presence of the angiogenetic 
phenomenon and to understand its pathogenetic mechanism. Materials and Methods: Thirty OLP patients and 
thirty healthy subjects were enrolled in a study. The immunohistochemical analysis of the VEGF and vascular-
endothelial adhesion molecules was carried out by means of primary antibodies and anti-CD34, anti-VEGF, anti-
CD106 antigen (VCAM-1) and anti-CD54 antigen (ICAM-1). The statistical significance of the differences was 
checked with the Mann-Whitney test (MW test). The level of significance was set to P<0.001. Data analysis was 
carried out with StatView 5.0.1 (SAS Institute Inc., Cary, NC). Results: The results reveal the presence of a sig-
nificant angiogenesis in OLP patients for the VEGF, CD34, CD106 and CD54 (P < 0.001).. The number of vessels 
in the biopsies of the patients with OLP (mean±SD: 21.27±4.85), compared with the healthy subjects (mean±SD: 
4.74±0.97) was significantly more (Mann-Whitney test, P < 0.001). The positive expression rate of VEGF, CD34, 
VCAM-1 and ICAM-1 in oral lichen samples was 64.2%, 54.3%, 32.5% and 29.7%, respectively. Isolated endothe-
lial cells and newly-formed micro-vessels and endothelial cells with high-immune-positivity to the antibodies 
anti-ICAM-1 and anti-VCAM-1 were observed. Conclusions: The results of our immunohistochemical research 
show that a significant neoangiogenesis occurs in oral lichen planus.
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Introduction  
Angiogenesis represents a cycle of vital processes that 
leads to the neoformation of anomalous blood vessels 
in pre-existing vascular structures (1). At the heart of 
angiogenesis is the endothelial cell that proliferates and 
differentiates under the regulatory action of vascular en-
dothelial growth factor (VEGF), the principal direct in-
ducer of angiogenesis together with other growth cofac-
tors. This process plays an important role both in physi-
ological conditions, such as embryonic development and 
the healing of wounds, and in pathological conditions, 
such as the growth of tumours and metastasis and the de-
velopment of chronic inflammatory diseases. Scientific 
studies (2-4) have shown the importance of angiogen-
esis in the chronic inflammatory mechanism and have 
verified the presence of neoangiogenesis in pathologies 
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such as rheumatoid arthritis, psoriasis, bronchial asthma, 
diabetic retinopathy, atherosclerosis and Alzheimer’s 
disease. Furthermore, recent studies (5) have confirmed 
a strong involvement of the angiogenetic phenomenon 
in other intestinal chronic inflammatory diseases such 
as Crohn’s Disease and ulcerous rectocolitis. It is known 
that angiogenesis plays a key role in the pathogenesis 
of chronic inflammatory illnesses, not only causing the 
gemmation of new vessels that allow a better oxygena-
tion and a greater contribution of metabolites to the pro-
liferating tissue, but also notably increasing the complex 
system of feed-back and turnover of the cells involved 
in the inflammatory process (6).  This feed-back mecha-
nism has been noticed (5) the presence - in isolated 
endothelial cells - of the prominent factor in the angio-
genetic phenomenon: VEGF. Oral lichen planus (OLP) 
is a pathology of the oral mucous of a chronic inflam-
matory autoimmune pathogenetic mechanism in which 
a rich vascular proliferation has been seen, probably 
as a reaction to the hypoxic effect on the stromal area, 
where the phlogistic reaction occurs due to the increase 
of proliferating lymphocytes (7-8). The markers VEGF, 
CD34,VCAM-1 and ICAM-1 are appropriate to investi-
gate the vascular endothelin and they have been used in 
the study to probe the presence of angiogenesis process 
and to underline endothelial modifications (9-10). In this 
research we evaluated the presence of the angiogenetic 
phenomenon in a series of biopsies of the oral mucous 
of patients with an anatomo-clinical diagnosis of lichen 
planus, with the aim of understanding its pathogenetic 
mechanism.   
Materials and Methods  
Thirty OLP patients (M/F: 24/6; mean±SD:54.8±0.23) and 
thirty healthy subjects (M/F: 22/8; mean±SD:52.5±0.57) 
were enrolled. The diagnosis of lichen planus has been 
effected according to the WHO diagnostic criteria of oral 
lichen planus. These criteria are based on clinical and 
histopathological characteristics. Clinical criteria are: 
presence of bilateral, more or less symmetrical lesions; 
presence of a lacelike network of slightly raised gray-
white lines (reticular pattern); erosive, atrophic, bullous 
and plaque-type lesions are only accepted as a subtype 
in the presence of reticular lesions else where in the oral 
mucosa. Histopathological criteria are: presence of a 
well-defined band-like zone of cellular infiltration that is 
confined to the superficial part of the connective tissue, 
consisting mainly of lymphocytes; Signs of ‘liquefaction 
degeneration’ in the basal cell layer; absence of epithelial 
dysplasia (11). Every patient which had lichenoid lesions 
objectively related to esogenic agents such as dental 
materials, medicines or specific allergens were excluded 
from the sample group (12). After having signed the 
informed consent the patients and the healthy subjects 
were submitted to an incisional biopsy through means 
of  a biopsy punch (ø = 4 mms). All the bioptic samples 
were analyzed using the same procedures and materials. 
For each sample, lined up in paraffin after being fixed in 
formalin, four sections of tissue around 5 µms thick were 
prepared in order to enable an immunohistochemical 
analysis of the vascular endothelial growth factor 
(VEGF) and vascular-endothelial adhesion molecules 
in the vascular endothelial cells. These sections were 
treated with primary antibodies (DAKO and Novocastra) 
anti-CD34, anti-VEGF, anti-CD106 antigen (VCAM-1) 
and anti-CD54 antigen (ICAM-1). The dilution of the 
primary antibodies was: 1:500 for anti – VEGF and 1:50 
for anti-CD106, anti-CD34 and anti CD-54. We have 
positive and negative immuunohistochemical controls 
for the different antibodies used.
The primary antibodies were revealed with the standard 
avidin-biotin method. Angiogenesis was valuated with a 
semiquantitative method counting for all the markers and 
in every histological section and in 5 random fields with 
high magnification (40X). The statistical significance of 
the differences was checked with the Mann-Whitney test 
(MW test). The level of significance was set to P<0.001. 
Data analysis was carried out with StatView 5.0.1 (SAS 
Institute Inc., Cary, NC).
Results  
The number of vessels in the biopsies of the patients 
with OLP (mean±SD: 21.27±4.85), compared with the 
healthy subjects (mean±SD: 4.74±0.97) was significantly 
increased (Mann-Whitney test, P <0.001). The positive 
expression rate of VEGF, CD34, VCAM-1 and ICAM-1 
in oral lichen samples were 64.2%, 54,3%, 32,5% and 
29,7%, respectively (Table 1).  Moreover in the context 
of the phlogistic process and in a random way, both iso-
lated endothelial cells immunopositive to the antibody 
anti-VEGF and neoformed microvessels and endothelial 
cells with high-immune-positivity to the antibodies anti-
ICAM-1 and anti-VCAM-1 were observed (Figs 1,2). In 
healthy subjects we had positive immunohistochemical 
results for the CD34. Instead, we had negative immuno-
histochemical results for the other antibodies. 
Discussion  
The angiogenetic phenomenon is considered fundamen-
tal in many physiological and pathological processes 
(13). In any type of angiogenetic process, both physio-
logical and pathological, the beginning of the angiogen-
ic response occurs with the activation of the endothelial 
cells due to the release of cytokine following hypoxia 
or ischemia. For this reason, such conditions become a 
prerequisite for the participation of the endothelial cells 
in the process of angiogenesis. Hypoxic tumour cells, 
macrophages and other cells of the immune system pro-
duce VEGF that provokes vasodilation, the increase of 
vascular permeability and the release of proteasis, which 
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Table 1. Conclusive results of the statistical analysis performed by Mann-Whitney U-test ( P<.001).
LPO patients Healthy subjects
Age 
(Mean±SD)
54.8±0.23 52.5±0.57
Gender
24/ F
6 /M
22/ F
8 /M
Number of vessels 
(Mean±SD)
21.27±4.85 4.74±0.97
Positive
Expression Rate                           
of Markers (%)
VEGF: 64,2%
CD34: 54,3%
CD106 ( VCAM-1):32,5%
CD54 ( ICAM-1): 29,7%
CD34: 18,3%
Statistical Signifi-
cance
(Mann Whitney test)
P<0.001
Significative values for
VEGF, CD34, VCAM-1 and ICAM-1
No-Significative 
value for CD34 
P>0.001
Fig. 1.  A-B) Control: poor  microcirculation subepithelially. C-D) Oral Lichen Planus: 
marked new-angiogenesis in lymphocytic infiltration (magnification 40X).
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is important for the invasion of cells and the remodelling 
of tissues (14-16). VEGF has a fundamental role in the 
physiological and pathological regulation of angiogen-
esis. In vitro, VEGF stimulates the degradation, the pro-
liferation and the migration of the endothelial cells. In 
vivo, it regulates vascular permeability, which is impor-
tant for the start of angiogenesis. Different mechanisms 
are involved in the regulation of the gene for VEGF. The 
tissue tension of O2 plays an important role, as shown 
by the reversible increase of the levels of m-RNA for 
VEGF under conditions of hypoxia in vivo and in vitro 
(17). The literature is not, at the moment, satisfactory 
and up-to-date compared with the study of the angio-
genetic phenomenon in OLP. As an autoimmune disease 
with an inflammatory origin and chronic progression, 
OLP satisfies all the prerequisites of hypoxia at the base 
of the angiogenetic mechanism in light of the hypoxic 
effect caused by the proliferating inflammatory elements 
that has also been found in the oral mucous with non-
histological or serological techniques, such as videocap-
illaroscopy (18). Studies effected on patients affected by 
OLP have had as their point of interest the increase of 
the number of mastocytes up to the level of the lamina 
itself. Such studies have proved how such an increase of 
density can, in effect, influence the vascular endothelia 
in a critical way and have an important role in the for-
mation phase of the lesion (19). Immunohistochemical 
studies performed in the past have suggested that there 
is the intervention of the angiogenetic phenomenon in 
the malignant transformation of a lot of precancerous 
lesions of the oral epithelium, including OLP, but such 
studies were hypothetical and aimed at the oncologic 
consequence of the lesion (20). 
Our research represents a direct assessment of the pres-
ence of the angiogenetic phenomenon in OLP since it 
is based on direct research and on histological samples 
of oral mucous, of VEGF – the principal factor for the 
angiogenetic process - and of other important factors of 
adhesion.         
The assessment of the expression of the inducer factors 
of angiogenesis represents an important departure point 
for the study of new therapies based on the use of anti-
angiogenetic medicines already used in other patholo-
gies with chronic inflammatory pathogenesis with good 
results. Moreover, the verified presence of angiogenesis 
in OLP could give further clarifications with respect to 
the ethiopathogenesis of OLP, which is still unknown 
today. In conclusion, the individualization of both lym-
phocytes in transit among the cubic endothelial cells of 
the neoformed vessels and adhesion molecules (anti-
VCAM-1 and anti-ICAM-1antibodies) in the endothe-
lial cells of such vessels, suggests that angiogenesis in 
the lichen not only restores tissue oxygenation but also 
develops an important role in the turnover of the inflam-
matory elements in the inflamed area and therefore in 
the self-perpetuation of the disease. 
Fig. 2. Oral Lichen Planus:  positivity of vessels neoformed to CD106 and CD54 antibodies 
cells (magnification 40X).
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